Works matching IS 0741238X AND DT 2021 AND VI 38 AND IP 3


Results: 24
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).

    Published in:
    Advances in Therapy, 2021, v. 38, n. 3, p. 1514, doi. 10.1007/s12325-021-01631-y
    By:
    • Katsuno, Tomoyuki;
    • Shiraiwa, Toshihiko;
    • Iwasaki, Shingo;
    • Park, Hyohun;
    • Watanabe, Nobuaki;
    • Kaneko, Shizuka;
    • Terasaki, Jungo;
    • Hanafusa, Toshiaki;
    • Imagawa, Akihisa;
    • Shimomura, Iichiro;
    • Ikegami, Hiroshi;
    • Koyama, Hidenori;
    • Namba, Mitsuyoshi;
    • Miyagawa, Jun-ichiro;
    • For the TRUST2 study group;
    • Seino, H.;
    • Nakata, S.;
    • Uchida, D.;
    • Komi, R.;
    • Ooka, A.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24